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Surface enhanced spatially offset Raman spectroscopy (SESORS) has the potential to 
serve as a tool for non-invasive, early detection of a variety of disease states, especially 
neurological disease. In this study, a great deal of preliminary work was completed in order to 
achieve the SESORS detection of major neurochemicals and their mixtures in a brain tissue 
mimic through bone. First, seven neurotransmitters were detected at physiological 
concentrations using surface enhanced Raman spectroscopy (SERS), and their individual limits 
of detection were established. Next, Teflon signal was collected through bone and brain tissue 
mimic at depths of 18 mm using spatially offset Raman spectroscopy (SORS). Then, a low 
concentration of serotonin was sensed in a mouse brain through the skull using SESORS. Finally, 
methods were developed to selectively capture and detect dopamine molecules using SERS. 
Introduction 
Neurotransmitters serve as possible biomarkers for neurological diseases, which are 
difficult to detect in their early stages when treatment would be most beneficial. The basic 
functions, structures, and physiological concentrations of several important neurotransmitters 
are shown in Table 1. For example, dopamine is linked to motor control and is involved in 
Parkinson’s disease. The death of dopamine-producing neurons in the substantia nigra of 
Parkinson’s patients results in loss of motor function (1), and the disease is typically not 
diagnosed until symptoms have caused irreversible damage. 
Recently, the need has been recognized for better methods to monitor neurochemicals 
in vivo. Current methods, such as microdialysis (2) and cyclic voltammetry (3), are highly  
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invasive and often involve removing portions of the skull to surgically implant the required 
technology. Raman spectroscopy, in particular SERS, has garnered attention as a possible tool 
for biosensing and disease diagnosis (4), yet in practice, SERS is also an invasive technique, since 
it requires obtaining bodily fluids or tissue samples for analysis. SESORS is unique in that it can 
provide highly selective, label free, and minimally invasive detection of low concentrations of 
chemicals with rapid sample analysis. SESORS could lead to earlier detection of neurological 
diseases and provide critical knowledge about their progression. 
 









Raman spectroscopy is an inelastic light scattering technique that provides information 
about the identity of a molecule based on its vibrational modes. For a vibration to be Raman 
active, the molecule must undergo a change in polarizability when it is excited to a virtual state 
with a monochromatic light source. When the molecule is excited, an induced dipole is created, 
according to the equation 𝜇 = 𝛼𝐸, where 𝛼 is the polarizability and 𝐸 is the electric field. Each 
Raman active molecule has a characteristic spectrum, or a “molecular fingerprint”. Raman 
signal is highly specific, sensitive, non-destructive, and can be rapidly collected. On the other 
hand, its major disadvantage is that it is inherently weak. Only one in every 107 incident 
photons is Raman scattered (5), so certain techniques must be used to enhance the strength of 
Raman signal, one of which is by increasing the electric field surrounding the molecule. 
Surface Enhanced Raman Spectroscopy 
Surface enhanced Raman spectroscopy (SERS) yields amplified Raman signal by taking 
advantage of the electric field produced by the excitation of conduction electrons on the 
surface of noble metal nanoparticles (6). This phenomenon is known as the localized surface 
plasmon resonance (LSPR). When a molecule encounters this electric field, its Raman signal can 
be enhanced by up to a factor of 108 (7). SERS enhancement allows for the identification and 




Spatially Offset Raman Spectroscopy 
Spatially offset Raman spectroscopy (SORS) enables the detection of Raman signal from 
the subsurface layers of diffusely scattering media. Photons enter the deeper layers of a 
sample, migrate laterally, and then exit the sample. To gather information from these 
subsurface layers, signal is collected at a point that is offset from the location of the incident 
light. Inverse SORS differs from conventional SORS in that it involves illuminating the sample in 
a circle and collecting the scattered light from a point in the center of the circle (8). The radius 
of the circle equals the degree of spatial offset. A larger offset permits incident photons to 
penetrate deeper in the sample, and Raman signal can be obtained from further beneath the 
surface of the sample. The combination of SERS and SORS gives surface enhanced spatially 
offset Raman spectroscopy, or SESORS. 
Experimental Methods 
Nanoparticle Synthesis and Characterization 
On a regular basis, gold nanoparticles (AuNPs) were synthesized using a citrate 
reduction method based on the procedure reported by Frens (9). Due to its lack of toxicity, gold 
is an excellent material for in vivo experimentation. Silver nanoparticles (AgNPs) were 
occasionally synthesized as well using the protocol outlined by Lee and Meisel (10). After each 
synthesis, the batch of nanoparticles was characterized using ultraviolet-visible extinction 
spectroscopy to identify its localized surface plasmon (Figure 2), which is an indication of the 
shape and size distribution of the particles. The LSPR of the gold colloids tended to be around 
540 nm, while that of the silver colloids was usually about 420 nm. To test their SERS activity, 
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100 µM benzenethiol- a common Raman reporter molecule was adsorbed onto the surface of 
the colloids for SERS analysis. At such a low concentration, no normal Raman signal could be 
obtained from the benzenethiol, but if the nanoparticles were SERS active, they enhanced the 
Raman signal of the molecule to a measurable level (Figure 3). Additionally, the nanoparticles 
were imaged using scanning electron microscopy (SEM) to better understand their structure 
(Figure 4). 
 
Figure 2: Localized surface plasmon resonance of AuNPs, with the maximum wavelength at 539 










      
Figure 4: SEM images of AuNPs (Adapted from Sharma group). 
 
Instrumentation 
The Sharma lab is equipped with homebuilt macro- and micro- Raman optical systems, 
which allow the group to perform experiments using normal Raman, SERS, SORS, and SESORS. 





collected in a 180° backscattering geometry. This system has the capability to achieve various 
spatial offsets using axicon lenses so that inverse SORS signal can be collected from the sample. 
The micro system (Figure 5) includes four laser sources with wavelengths of 488 nm, 532 nm, 
633 nm, and 785 nm on the same beam path, and it incorporates a confocal microscope to 
focus the laser light onto the sample before it is collected by the spectrometer. Only the 785 
nm laser is represented in the figure below. 
     
  




Normal Raman and SERS Measurements of Seven Neurotransmitters 
Dopamine, serotonin, melatonin, glutamate, GABA, epinephrine, and norepinephrine 
were purchased in their solid forms, and their normal Raman spectra were acquired using 
excitation wavelengths of 532 nm (Figure 6), 633 nm (Figure 7), and 785 nm (Figure 8). The solid 
state data provided information about the major vibrations of each molecule. It also showed 
that although the positions of the vibrations were consistent in each spectrum, certain 
vibrations were more intense at different wavelengths. Since the intensity of Raman signal 




4), the strongest signal was observed at 532 nm. The spectra of GABA and glutamate 
displayed much weaker Raman signal than the other neurotransmitters because they have 
linear structures and lack rings containing conjugated pi bonds. These spectra were used as a 
basis for understanding the Raman bands that would be expected from the neurotransmitters 

























Figure 8: Spectra of solid neurotransmitters at 𝜆𝑒𝑥 = 785 nm, P=10 mW, t=30 s (11). 
 
Next, a series of SERS spectra were collected for the seven neurochemicals. In order to 
maximize the intensity of the SERS signal, the optimum experimental conditions were 
determined. For instance, the centrifuging speeds and durations for both the gold and silver 
particles were optimized to remove the maximum number of particles from the supernatant. 
The best centrifuging conditions were 4200 rpm for 15 minutes for gold and 5000 rpm for five 
minutes, a total of two times, for silver.  
Additional optimization included adjusting the amount of time that the analyte was 
allowed to incubate with the nanoparticles before the SERS measurements were taken, along 
with changing the pH of the nanoparticle solution. The neurotransmitter solutions gave the 
strongest SERS signal after an hour of incubation and at a pH of 3. Decreasing the pH of the 
nanoparticles effectively protonated their negatively charged surfaces, which allowed the 
neurotransmitters to more favorably adsorb onto the colloids. The negatively charged citrate 
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molecules remaining on the nanoparticle surface create the repulsive forces that keep the 
nanoparticles dispersed in solution. At a pH below 3, the nanoparticles become unstable and 
quickly aggregate and fall out of solution. 
Various concentrations (between 1 nM and 500 µM) of the neurotransmitter of interest 
were adsorbed onto gold nanoparticles with a pH of 3, and SERS signal was obtained at 633 nm 
and 785 nm excitation wavelengths. The same concentrations of neurotransmitters were 
adsorbed onto silver nanoparticles as well, and the solutions were excited at wavelengths of 
532 nm, 633 nm, and 785 nm to obtain SERS signal. Figure 9 shows the SERS spectra at 785 nm 
of four concentrations of melatonin and exemplifies the proportional relationship between 
analyte concentration and SERS intensity in this range.  
 
Figure 9: SERS of melatonin on AuNPs. ex=785 nm, P=5 mW, t=60 s (12). 
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Shown below are the spectra at two excitation wavelengths for 50 µM concentrations of 
each of the seven neurochemicals on gold colloids (Figures 10 and 11). Each molecule exhibits a 
distinct Raman spectrum, which demonstrates the chemical specificity of the approach.  
 
Figure 10: SERS of 50 µM neurotransmitter solutions on AuNPs. ex=633 nm, P=3 mW, t=60 s 
(11). 
 





Given that the amount of data collected during this study was quite large, spectral 
differences were difficult to discern by eye. Therefore, principle component analysis (PCA) was 
used to analyze the spectra, distinguish differences between them, and determine limits of 
detection. PCA is a multivariate mathematical technique that reduces the number of variables 
in a data set into principal components, which are represented by loadings that serve as 
reference spectra to which the software compares each sample. In PCA, the first principal 
component has the largest variance, which means it represents the source of the largest 
variability in the data. Each successive principle component represents the next highest source 
of variance. When the principle components are graphed, samples with similar scores cluster, 
meaning that they are highly similar. In this experiment, the limit of detection of a molecule 
was defined as the spectrum of lowest concentration that was discernably different from, or 
not clustered with, the other spectra. Two representative PCA graphs, along with the loadings 
for their principle components, are shown here (Figures 12 and 13), and the various clusters of 
neurotransmitters have been circled. The limits of detection of each neurotransmitter using 








Figure 13: PCA of neurotransmitters (800 nM to 1 nM) on AuNPs at 633 nm (11). 
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Neurotransmitter AgNPs @  
532 nm 
AgNPs @  
633 nm 
AgNPs @  
785 nm 
AuNPs @  
633 nm 




Melatonin 50 μM 50 μM 200 nM 100 nM 100 nM 100 nM 
Serotonin 200 nM 100 nM 200 nM 100 nM 100 nM 1 μM 
Glutamate 50 μM 600 nM 10 μM -- -- 1 μM 
Dopamine 10 μM 10 μM 10 μM 100 nM 100 nM 1 μM 
GABA 500 μM 100 nM 200 nM -- -- 1 mM 
Norepinephrine 10 μM 10 μM 10 μM 100 nM 200 nM 3 μM 
Epinephrine 10 μM 10 μM 500 μM 10 μM 10 μM 1 mM 
Figure 14: Limits of detection of neurotransmitters using SERS (11). 
 
SERS Measurements of Neurotransmitter Mixtures 
Since neurochemicals rarely exist naturally in isolation, SERS experiments were also 
performed in more complex environments using mixtures of neurotransmitters. First, a mixture 
was prepared using 50 μM concentrations of all seven neurotransmitters in water. A second 
aqueous mixture was made using concentrations of the seven neurotransmitters based on the 
quantities typically found in the human brain. The SERS spectra of these mixtures on gold 
nanoparticles at 785 nm are shown in Figure 15. Individual characteristic peaks of the majority 
of the neurotransmitters can be seen and are labeled in this figure. The same peaks appear in 
both mixtures, although they exhibit different intensities when the proportions of the 




Figure 15: SERS of mixtures of neurotransmitters on AuNPs. ex=785 nm, P=5 mW, t=60 s 
(Adapted from Sharma group). 
 
SORS Depth Study 
Next it was shown that the inverse SORS detection of Teflon- another common Raman 
reporter- could be achieved through a 1 mm piece of bone and up to 18 mm of agarose gel, 
which serves as a brain tissue mimic. Square pieces of agarose gel were prepared, each with a 
thickness of 2 mm. A flat portion of a rat skull was placed in front of a piece of Teflon, and a 785 
nm laser was focused onto the bone. A Raman spectrum was collected in this position, termed 
the 0 mm offset, before an axicon was placed in the laser line to create a 4 mm annular beam 
on the bone, achieving a 2 mm offset. Slices of the brain tissue mimic were placed in 2 mm 
increments between the bone and the Teflon, and the SORS measurements were repeated at 
both offsets until no Teflon signal could be seen using the 2 mm offset. For each depth, a scaled 
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subtraction was performed. The 0 mm offset spectrum was subtracted from the 2 mm offset 
spectrum to remove the contribution of the bone and make the Teflon signal more easily 
visible. As can be seen in Figure 16, the Teflon peak at 734 cm-1 persisted until the agarose gel 
thickness reached 20 mm. This study demonstrated the viability of inverse SORS as a method 
for obtaining Raman signal from the human brain through the skull, which is only 3 mm thick at 
the substantia nigra. 
 
  
Figure 16: SORS of Teflon through bone and increasingly greater depths of agarose gel. ex=785 







SESORS of Neurotransmitters in a Brain Tissue Mimic through the Skull 
Because Raman signal is weak, it would be difficult to obtain neurochemical information 
using SORS alone; it was important to show that a spatial offset could be combined with surface 
enhancement to achieve the SESORS detection of low concentrations of neurotransmitters in a 
brain tissue mimic through bone. Pieces of agarose gel were incubated with 100 μM 
neurotransmitter solutions for one hour to mimic brain slices with neurochemicals present. 
Then, gold nanoparticle solutions with a pH of 3 were added to the gels and allowed to 
incubate for another hour. The samples were placed onto the sample holder of the macro 
system and the SESORS signal of each was acquired at 785 nm through the piece of rat skull 
mentioned earlier. Before collecting the final data, experimental parameters such as the time 
the analyte was allowed to incubate on the gel and the degree of spatial offset were optimized 
to achieve maximum SESORS signal. A 2 mm offset provided the strongest signal. The 
procedure was repeated with mixtures of neurotransmitters, such as melatonin mixed with 
dopamine, serotonin mixed with dopamine, and serotonin mixed with melatonin.  
The data was processed by subtracting the 0 mm offset from the 2 mm offset to remove 
the majority of the bone signal at 960 cm-1. For a few of the samples, figures were compiled 
showing the 0 mm offset spectrum, the 2 mm offset spectrum, the subtracted spectrum, and 
the spectrum of the gel alone (Figures 17 – 20). Characteristic peaks from the 
neurotransmitters were observed in all of the spectra, including the spectra of the mixtures. 
Overall, by using a 2 mm offset- versus a 0 mm offset- more signal was obtained through bone 
from the neurotransmitter or neurotransmitters of interest. The ratio of analyte signal to bone 
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signal increased as the offset increased. In other words, by employing a greater offset, more 
scattered light was being collected from the brain tissue mimic beneath the bone. 
 
Figure 17: SESORS data for serotonin in agarose gel through bone. ex=785 nm, P=90 mW, 







Figure 18: SESORS data for dopamine in agarose gel through bone. ex=785 nm, P=90 mW, 
t=120 s (12). 
 
 
Figure 19: SESORS data for melatonin in agarose gel through bone. ex=785 nm, P=90 mW, 






Figure 20: SESORS data for a serotonin and dopamine mixture in agarose gel through bone. 
ex=785 nm, P=90 mW, t=120 s. 
 
SESORS Detection of Serotonin in vivo (Mouse Model) 
A sacrificed mouse was obtained from the Sparer group at the University of Tennessee. 
The head was shaved, and a SORS spectrum was acquired through the skull using a 785 nm 
laser at a 0 mm offset (Figure 21). Since bone is partially transparent at this wavelength and the 
mouse skull is very thin, some subsurface information was gathered even at a 0 mm offset. The 
observed peaks corresponded to bone and decomposing tissue in the brain. The skull was 
opened, and 100 µM serotonin and gold nanoparticles were injected into the brain. The bone 
was measured to be about 0.5 mm to 0.8 mm thick, suggesting that a 1 mm offset would allow 
chemical information to be retrieved from the brain. The skull was replaced, and another 
spectrum was acquired with no offset (Figure 21). Finally, a SESORS spectrum was collected at a 
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1 mm offset. The final two spectra exhibit peaks at 820 cm-1, 1221 cm-1, 1341 cm-1, and 1522 
cm-1, which are characteristic of serotonin (Figure 21), meaning that this technique has the 
ability to detect neurotransmitters in vivo through the skull. 
 
Figure 21: Initial SORS spectrum of the mouse brain through the skull (top, blue). SESORS 
spectrum (with initial SORS spectrum subtracted) of the mouse brain through the skull after a 
100 µM serotonin injection at 0 mm offset (red, middle) and at 1 mm offset (green, bottom). 
ex=785 nm, P=90 mW, t=120 s (13). 
 
Selective Detection of Dopamine using Boronic Acid 
Selectively targeting molecules of interest would allow for better SESORS detection of 
neurochemicals in the brain. In order to selectively capture and detect dopamine molecules in a 
brain tissue mimic, boronic acids were employed as capture ligands. A 100 µM solution of 4-
mercaptophenylboronic acid (4-MPBA) was prepared in PBS. The sulfur groups of the acid 
molecules were bound to the surface of gold nanoparticles, leaving the diol groups available to 
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target the diol groups of dopamine. Various concentrations of dopamine were added to the 
boronic acid-conjugated gold nanoparticles (BA-AuNPs) and were allowed to incubate for one 
hour. Then, the solutions were added to pieces of agarose gel, and SERS spectra were collected 
24 hours later. The SERS data collected after the full day incubation period is displayed below 
(Figure 22). The bands at 1006 cm-1, 1258 cm-1, 1344 cm-1, and 1448 cm-1 correspond to 
dopamine, while the other peaks represent the contribution from the remaining boronic acid 
molecules and gold nanoparticles in the gel. These peaks correlate well with those observed by 
Yu et al. in their SERS data of dopamine on silver nanoparticle dimers (14). This data suggests 
that boronic acid-functionalized gold nanoparticles are a viable option for achieving the 
selective SERS detection of dopamine. 
 




Conclusions and Future Work 
The series of experiments outlined in this work represent the groundwork for using 
SESORS for the in vivo diagnosis of neurological disease. First, gold and silver nanoparticles 
were successfully synthesized and were used to detect low concentration of various 
neurotransmitters at multiple excitation wavelengths using SERS. With the help of PCA, the 
limits of detection of our method were established for seven neurotransmitters under various 
experimental conditions. Individual neurotransmitters were detected within physiologically 
representative mixtures. Serotonin, dopamine, melatonin, epinephrine, and norepinephrine 
were identified at concentrations of 100 µM in a brain tissue mimic through a rat skull using 
SESORS. Then, mixtures of serotonin, dopamine, and melatonin were detected using the same 
methodology. After 24 hours of incubation, dopamine was captured using boronic acid-
conjugated nanoparticles, and signal was obtained using SERS.  
There remains a significant amount of work to be done in the future to develop a 
SESORS technique to be used in the clinical setting. For instance, the brain contains numerous 
biomolecules, so steps should be taken to improve the selective detection of the 
neurotransmitters of interest. The selectivity of the BA-AuNPs described above should be 
tested on dopamine in the presence of other neurotransmitters and other biological molecules. 
The BA-AuNPs should be incorporated into SESORS experiments to detect dopamine signal 
through bone, and they should be used to sense dopamine in the brain of an animal model. 
Eventually, this technology is likely to be tailored for use in patient care, as SESORS shows great 
promise as a diagnostic tool. In conclusion, this work represents the first steps in developing a 
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